News
Promising new way to modulate brain cell activity to potentially treat major depressive disorder in adults. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 05 ...
11d
The Brighterside of News on MSNOne dose of ketamine could treat depression for months, study findsRoughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...
The major depressive disorder medication, BHV-7000, is different than those that focus on serotonin because it focuses on potassium channels, which help regulate the activity of neurons in the brain.
Topline data were announced from a phase 3 trial evaluating navacaprant for the treatment of major depressive disorder (MDD). Navacaprant is a highly selective kappa opioid receptor (KOR ...
Major depressive disorder impacts peripheral artery disease risk through intermediary risk factors. J Am Heart Assoc . 2024 Feb 20;13(4):e030233. doi: 10.1161/JAHA.123.030233. Epub 2024 Feb 16.
Rates of depression notably spiked during the pandemic. But even though life has largely returned to normal, we’re still in a mental health crisis. In 2023, the U.S. Surgeon General declared an ...
Source Reference: Butterfield NN, et al "Azetukalner, a novel K V 7 potassium channel opener, in adults with major depressive disorder: a randomized clinical trial" JAMA Netw Open 2025; DOI: 10. ...
The biomarker-defined MDD patient group treated with ALTO-100 did not demonstrate a statistically significant improvement in depressive symptoms compared to placebo.
But this year, the U.S. Food and Drug Administration cleared the first app-based treatment for major depressive disorder, which just became available for use this summer.
Study: Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause.Image Credit: SpeedKingz/Shutterstock.com. Background. Perimenopause ...
The major depressive disorder medication, BHV-7000, is different than those that focus on serotonin because it focuses on potassium channels, which help regulate the activity of neurons in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results